Healthcare >> CEO Interviews >> June 7, 1999
DR. JAMES F. PICKARD is Chief Executive of Core Technologies plc. He was
educated at Paisley College of Technology and the Universities of
Strathclyde and Manchester. His qualifications include BSc (Pharmacy)
and PhD (Pharmaceutical Technology). Dr. Pickard spent nine years
working in the Research & Development Department of Sandoz AG in Basles,
and then five years as U.K. Research Director for Apothekernes
Laboratorium A/S in Oslo. In 1983, he established his own business,
providing specialist consultancy services to the pharmaceutical
industry. In 1986, Dr. Pickard was appointed as Managing Director of
Controlled Therapeutics (Scotland) Ltd (CTS), a company specializing in
drug delivery technologies, which he founded in Scotland on behalf of a
group of American investors. CTS was floated on the American Stock
Exchange through a reverse merger with a quoted company in 1989,
followed by several equity restructuring deals. During this time the
company launched its first drug delivery product on the U.K. market. Dr.
Pickard led the team which founded Core Technologies Ltd in 1992 and has
taken it through several rounds of private finance totaling 11 million
to a full listing on the London Stock Exchange in 1997 to raise a
further 25 million. Core has several platform technologies, which are
used for the controlled, sustained release of drug substances. Profile
enough information to put us into context as what you see as your
business, and what you see as your company today.
Dr.
